Article
RBM20 variants disrupt Ca2+ handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.
Signal transduction and targeted therapy - 14 Jul 2026
Rebs Sabine, Sedaghat-Hamedani Farbod, Kayvanpour Elham, Eberl Hanna, Berečić Branimir, Dudek Jan, Wagensohner Nicole, Seedorf Aylin, Unsöld Julia K, Hübscher Daniela, Reich Christoph, Klein Teresa, Doose Sören, Nikolaev Viacheslav O, Buchwald Tjark, Wagdi Ahmed, Kohlhaas Michael, Dybkova Nataliya, Morais Costa Patricia, Guan Kaomei, Hasenfuss Gerd, Rog-Zielinska Eva A, Sossalla Samuel, Sauer Markus, Maack Christoph, Tiburcy Malte, Meder Benjamin, Streckfuss-Bömeke Katrin
Abstract excerpt
Mutations in the splice-regulator RBM20 cause heart failure with reduced ejection fraction (HFrEF), typically manifesting as dilated cardiomyopathy (DCM). Mutations at position 634 in the RS-domain cause DCM with (R634L) or without (R634W) left ventricular non-compaction (LVNC). However, the mechanisms underlying phenotype variability and personalized therapy beyond HFrEF remain unclear. We generated induced...
Topics
Join the communities discussing this publication.
